XTalks

JUNE 14, 2022

The US Food and Drug Administration (FDA) found the 0.3 Previous and emerging research on this bacterium has associated it with intrinsic multi-drug resistance and nosocomial infections (also referred to as hospital-acquired infections). is known for its brand of anti-snoring over-the-counter products.

Contamination 52

Contamination Bacterium Bacteria Branding 52

Pharma in Brief

NOVEMBER 20, 2023

The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations. In its August 16, 2023 decision in Le-Vel Brands, LLC v. Natural health product vs. regulated drug In Winning Combination Inc.

Production 52

Production Cosmetics Regulation Branding 52

Roots Analysis

NOVEMBER 11, 2023

The Centers for Disease Control and Prevention (CDC) recently issued a formal health advisory in response to an unprecedented outbreak of carbapenem-resistant Pseudomonas aeruginosa (CRPA), a bacterium notorious for its resistance to specific antibiotics, thereby instigating severe infections in affected individuals.

Contamination 52

Contamination Bacterium Branding Bacteria 52